Alfresa Holdings (2784) · FactFirst stated
FY2022 Q3 R&D expenses: ¥1.055 billion
First written in FY2022-Q3. . Latest entry: FY2022-Q3.
1entries
1years
0from disclosures
How it moved
Same theme, other companies
Decline in R&D Expenses with No Change in Activity StatusA theme 50 companies write about · 22 as a headwind · 11 as a tailwind
0 other companies' latest entry also says "First stated".
Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 50 companies compared. The sentences above are computed from all 50.Full recordFilings, disclosures and news, newest first